Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
16.80
+1.32 (8.53%)
At close: Nov 11, 2026, 4:00 PM EST
16.84
+0.04 (0.24%)
After-hours: Nov 11, 2026, 5:39 PM EST
Erasca Market Cap
Erasca has a market cap or net worth of $5.88 billion as of November 11, 2026. It is the 3,404th most valuable company in the world and the 1,108th biggest in the United States. Its market cap has increased by 804.55% in one year.
Market Cap
5.88B
Enterprise Value
5.54B
1-Year Change
804.55%
Global Rank
Country Rank
#1,108 United States
Category
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $5.88B, an increase of 216.21%. That is a compound annual growth rate of 24.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 5.87B | 456.42% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ligand Pharmaceuticals | 6.29B |
| Veradermics | 6.19B |
| Mirum Pharmaceuticals | 6.17B |
| Scholar Rock Holding | 5.85B |
| Cogent Biosciences | 5.51B |
| PTC Therapeutics | 5.36B |
| Edgewise Therapeutics | 5.10B |
| Dianthus Therapeutics | 5.04B |